Sex ratio among childhood cancers by single year of age

Pediatric Blood and Cancer

Volumn 66, Issue 6, 2019, Pages

  Williams, Lindsay A ^a   Richardson, Michaela ^a   Marcotte, Erin L ^a,b   Poynter, Jenny N ^a,b   Spector, Logan G ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

childhood cancer incidence; epidemiology; sex differences

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; ARTICLE; BONE TUMOR; BURKITT LYMPHOMA; CANCER INCIDENCE; CHILD; CHILDHOOD CANCER; FEMALE; GENDER; GERM CELL TUMOR; HEPATOBLASTOMA; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MELANOMA; NEPHROBLASTOMA; NEUROBLASTOMA; NEWBORN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETINOBLASTOMA; SEX RATIO; SOFT TISSUE SARCOMA; THYROID CARCINOMA; CANCER REGISTRY; CLASSIFICATION; FOLLOW UP; INCIDENCE; NEOPLASM; PRESCHOOL CHILD; PROGNOSIS; REGISTER; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; PROGNOSIS; REGISTRIES; SEER PROGRAM; SEX RATIO; UNITED STATES; YOUNG ADULT;

EID: 85062354608     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.27620     Document Type: Article

References (52)

1. American Cancer Society. Cancer in children and adolescents. Spec Sect Cancer Child Adolesc. 2014;1(ICCC):25–42. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2014/. Accessed 6, 2018.
2. Gurney J, Severson R, Davis S, Robison L. Incidence of Cancer in children in the United States. Cancer. 1995;75:2186–2195.
3. Johnson KJ, Carozza SE, Chow EJ, et al. Parental age and risk of childhood cancer: a pooled analysis. Epidemiology. 2009;20:475–483. https://doi.org/10.1097/EDE.0b013e3181a5a332.
4. Williams LA, Richardson M, Kehm RD, et al. The association between sex and most childhood cancers is not mediated by birthweight. Cancer Epidemiol. 2018;57:7–12.
5. O'Neill KA, Murphy MFG, Bunch KJ, et al. Infant birthweight and risk of childhood cancer: international population-based case control studies of 40 000 cases. Int J Epidemiol. 2015;44:153–168. https://doi.org/10.1093/ije/dyu265.
6. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence—SEER 18 Regs Research Data, Nov 2017 Sub (2000–2015). http://www.seer.cancer.gov. Accessed 6, 2018
7. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer. 2005;103:1457–1467. https://doi.org/10.1002/cncr.20910.
8. Mbulaiteye SM, Biggar RJ, Bhatia K, Linet MS, Devesa SS. Sporadic childhood Burkitt lymphoma incidence in the United States during 1992–2005. Pediatr Blood Cancer. 2009;53:366–370. https://doi.org/10.1002/pbc.22047.
9. Cartwright RA, Gurney KA, Moorman AV. Sex ratios and the risks of haematological malignancies. Br J Haematol. 2002;118:1071–1077. https://doi.org/10.1046/j.1365-2141.2002.03750.x.
10. Xu H, Zhang H, Yang W, et al. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nat Commun. 2015;6(Jun 24):7553. https://doi.org/10.1038/ncomms8553.
11. Rosemberg S, Fujiwara D. Epidemiology of pediatric tumors of the nervous system according to the WHO 2000 classification: a report of 1,195 cases from a single institution. Child's Nerv Syst. 2005;21:940–944. https://doi.org/10.1007/s00381-005-1181-x.
12. Sun T, Plutynski A, Ward S, Rubin JB. An integrative view on sex differences in brain tumors. Cell Mol Life Sci. 2015;72:3323–3342. https://doi.org/10.1007/s00018-015-1930-2.
13. Heuch JM, Heuch I, Akslen LA, Kvåle G. Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. Int J Cancer. 1998;77:498–503. https://doi.org/10.1002/(SICI)1097-0215(19980812)77:4<498::AID-IJC4>3.0.CO;2-P.
14. Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res. 2009;156:167–172. https://doi.org/10.1016/j.jss.2009.03.098.
15. Bjorge T, Sorensen HT, Grotmol T, et al. Fetal growth and childhood cancer: a population-based study. Pediatrics. 2013;132:e1265–e1275. https://doi.org/10.1542/peds.2013-1317.
16. Chow EJ, Puumala SE, Mueller BA, et al. Childhood cancer in relation to parental race and ethnicity: a 5-state pooled analysis. Cancer. 2010;116:3045–3053. https://doi.org/10.1002/cncr.25099.
17. Lunde A, Melve KK, Gjessing HK, Skjærven R, Irgens LM. Genetic and environmental influences on birth weight, birth length, head circumference, and gestational age by use of population-based parent-offspring data. Am J Epidemiol. 2007;165:734–741. https://doi.org/10.1093/aje/kwk107.
18. Michalski AM, Richardson SD, Browne ML, et al. Sex ratios among infants with birth defects, National Birth Defects Prevention Study, 1997–2009. Am J Med Genet Part A. 2015;167:1071–1081. https://doi.org/10.1002/ajmg.a.36865.
19. Bishop J, Huether CA, Torfs C, Lorey F, Deddens J. Epidemiologic study of Down syndrome in a racially diverse California population, 1989–1991. Am J Epidemiol. 1997;145:134–147. https://doi.org/10.1093/oxfordjournals.aje.a009084.
20. Johnson KJ, Lee JM, Ahsan K, et al. Pediatric cancer risk in association with birth defects: a systematic review. PLoS One. 2017;12:1–56. https://doi.org/10.1371/journal.pone.0181246.
21. Hasle H, Haunstrup Clemmensen I, Mikkelsen M. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet. 2000;355:165–169. https://doi.org/10.1016/S0140-6736(99)05264-2.
22. Spatz A, Borg C, Feunteun J. X-chromosome genetics and human cancer. Nat Rev Cancer. 2004;4:617–629. https://doi.org/10.1038/nrc1413.
23. Dunford A, Weinstock DM, Savova V, et al. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat Genet. 2017;49:10–16. https://doi.org/10.1038/ng.3726.
24. Kukurba KR, Parsana P, Balliu B, et al. Impact of the X chromosome and sex on regulatory variation. Genome Res. 2016;26:768–777. https://doi.org/10.1101/gr.197897.115.
25. Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol. 2010;10:594–604. https://doi.org/10.1038/nri2815.
26. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626–638. https://doi.org/10.1038/nri.2016.90.
27. Granados A, Gebremariam A, Lee JM. Relationship between timing of peak height velocity and pubertal staging in boys and girls. J Clin Res Pediatr Endocrinol. 2015;7:235–237. https://doi.org/10.4274/jcrpe.2007.
28. Lenroot RK, Giedd JN. Sex differences in the adolescent brain. Brain Cogn. 2010;72:1–19. https://doi.org/10.1016/j.bandc.2009.10.008.
29. Treviño LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1001–1005. https://doi.org/10.1038/ng.432.
30. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1006–1010. https://doi.org/10.1038/ng.430.
31. Orsi L, Rudant J, Bonaventure A, et al. Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia. 2012;26:2561–2564. https://doi.org/10.1038/leu.2012.148.
32. Wiemels JL, Walsh KM, de Smith AJ, et al. GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21. Nat Commun. 2018;9:286. https://doi.org/10.1038/s41467-017-02596-9.
33. Hunger SP, Mullighan CG. Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. Blood. 2015;125:3977–3988. https://doi.org/10.1182/blood-2015-02-580043.
34. Wang SL, Zhao H, Zhou B, et al. Polymorphisms in ERCC1 and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population. Leuk Res. 2006;30:1341–1345. https://doi.org/10.1016/j.leukres.2006.03.027.
35. Singh SK, Lupo PJ, Scheurer ME, et al. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore). 2016;95:e5300. https://doi.org/10.1097/MD.0000000000005300.
36. Washburn T, Medearis D, Child B. Sex differences in susceptibility to infections. Pediatrics. 1965;35:57–64.
37. Piccini P, Montagnani C, De Martino M. Gender disparity in pediatrics: a review of the current literature. Ital J Pediatr. 2018;44:4–9. https://doi.org/10.1186/s13052-017-0437-x.
38. Curran EK, Godfrey J, Kline J. Mechanisms of immune tolerance in leukemia and lymphoma. Trends Immunol. 2017;38:513–525. https://doi.org/10.1016/j.it.2017.04.004.
39. Taylor GM, Dearden S, Payne N, et al. Evidence that an HLA-DQAI-DQBI haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology. Br J Cancer. 1998;78:561–565.
40. Markle JG, Fish EN. SeXX matters in immunity. Trends Immunol. 2014;35:97–104. https://doi.org/10.1016/j.it.2013.10.006.
41. Mirabello L, Pfeiffer R, Murphy G, et al. Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control. 2011;22:899–908. https://doi.org/10.1007/s10552-011-9763-2.Height.
42. Biro FM, Lucky AW, Huster GA, Morrison JA. Pubertal staging in boys. J Pediatr. 1995;127:100–102. https://doi.org/10.1016/S0022-3476(95)70265-2.
43. Biro FM, Greenspan LC, Galvez MP. Puberty in girls of the 21st century. J Pediatr Adolesc Gynecol. 2012;25:289–294. https://doi.org/10.1016/j.jpag.2012.05.009.
44. Singh D, Sanyal S, Chattopadhyay N. The role of estrogen in bone growth and formation: changes at puberty. Cell Health Cytoskelet. 2011:1–12. https://doi.org/10.2147/CHC.S8916.
45. Khan D, Ahmed SA. The immune system is a natural target for estrogen action: opposing effects of estrogen in two prototypical autoimmune diseases. Front Immunol. 2016;6(January):1–8. https://doi.org/10.3389/fimmu.2015.00635.
46. Khan D, Ahmed A. Estrogen and signaling in the cells of the immune system. Adv Neuroimmune Biol. 2012;3:73–93. https://doi.org/10.3233/NIB-2012-012039.
47. Furman D, Hejblum BP, Simon N, et al. Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci. 2014;111:869–874. https://doi.org/10.1073/pnas.1321060111.
48. Ruigrok ANV, Salimi-Khorshidi G, Lai MC, et al. A meta-analysis of sex differences in human brain structure. Neurosci Biobehav Rev. 2014;39:34–50. https://doi.org/10.1016/j.neubiorev.2013.12.004.
49. Ries L, Smith M, Gurney J, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. NIH Pub No 99-4649. 1999:179 pp.
50. Spector LG, Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer. 2012;59:776–779. https://doi.org/10.1002/pbc.
51. Poynter JN, Amatruda JF, Ross JA. Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006. Cancer. 2010;116:612–625. https://doi.org/10.1002/cncr.25454.Trends.
52. Møller H, Evans H, Oliver T, et al. Epidemiology of gonadal germ cell cancer in males and females. APMIS. 2003;111:43–48. https://doi.org/10.1034/j.1600-0463.2003.11101071.x.